nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A specific GPR56/ADGRG1 splicing isoform is associated with antidepressant response in major depressive disorder
|
Lion, Montaine |
|
|
93 |
C |
p. 5-14 |
artikel |
2 |
Classical psychedelics in therapy: Essential psychotherapy or minimal support?
|
Knudsen, Gitte M |
|
|
93 |
C |
p. 27-28 |
artikel |
3 |
Differential effects of Xanomeline-trospium chloride on positive and negative symptoms in Schizophrenia: The role of dose
|
Hung, Tzu-Yen |
|
|
93 |
C |
p. 22-23 |
artikel |
4 |
3D imaging and geometric morphometrics of facial dysmorphology and asymmetry indicate gestational timings of dysmorphogenesis in schizophrenia and bipolar disorder
|
Waddington, John L. |
|
|
93 |
C |
p. 1-2 |
artikel |
5 |
Disease continuum centered on Parkinson's disease
|
Zheng, Ming |
|
|
93 |
C |
p. 19-21 |
artikel |
6 |
Editorial Board
|
|
|
|
93 |
C |
p. ii |
artikel |
7 |
Improvements in functioning and workplace productivity with esketamine nasal spray versus quetiapine extended release in patients with treatment resistant depression: Findings from a 32-week randomised, open-label, rater-blinded phase IIIb study
|
Vieta, Eduard |
|
|
93 |
C |
p. 29-39 |
artikel |
8 |
Lack of antidepressant-like effect of imipramine, fluoxetine and ketamine in the forced swim test in mice: How much standardization does a positive control require?
|
Medeiros, Marcela Verginia de |
|
|
93 |
C |
p. 24-26 |
artikel |
9 |
Lack of transparency on baseline pharmacological treatments in Clinical High-Risk for psychosis (CHR-P) may degrade precision: A systematic review and meta-analysis
|
Raballo, Andrea |
|
|
93 |
C |
p. 58-65 |
artikel |
10 |
Low dose oral ketamine treatment on post-traumatic stress disorder (PTSD) (OKTOP): An open-label pilot study
|
Quigley, Bonnie L. |
|
|
93 |
C |
p. 17-18 |
artikel |
11 |
Measuring the clinical dimensions of negative symptoms through the Positive and Negative Syndrome Scale
|
Wolpe, Noham |
|
|
93 |
C |
p. 68-76 |
artikel |
12 |
MiRNAs and extracellular vesicles in psychiatry: Potential biomarkers, therapeutic advances, and animal models
|
Miquel-Rio, Lluis |
|
|
93 |
C |
p. 3-4 |
artikel |
13 |
Preliminary evidence should be treated as such: Response to βIs creatine useful as adjuvant in cognitive-behavioural therapy for depression?β
|
De Giorgi, Riccardo |
|
|
93 |
C |
p. 15-16 |
artikel |
14 |
Prescription sequences in bipolar disorder β A nationwide Danish register-based study of 19,927 individuals followed for 10 years
|
Jorgensen, Anders |
|
|
93 |
C |
p. 51-57 |
artikel |
15 |
The role of esketamine in persistent long COVID with predominant psychiatric manifestations
|
Bozic, Ina |
|
|
93 |
C |
p. 66-67 |
artikel |
16 |
Whole-brain functional neuroimaging correlates of cognitive flexibility impairments in people with mental disorders: A transdiagnostic coordinate-based meta-analysis
|
Meda, Nicola |
|
|
93 |
C |
p. 40-50 |
artikel |